MyapplePharma

DESCRIPTION Evergraf 0.5mg belongs to class of anti-cancer drugs Evergraf 0.5mg contains an active compound known as Everolimus which interferes with the development of cancer cell and the process is slowing down. Evergraf 0.5mg tablets is not a curable medication, which helps to slow their spreading into the body. PRESCRIBED FOR The drug Evergraf 0.5mg is mainly used for the treatment of the following disease • kidney carcinoma • Breast carcinoma • Brain carcinoma Evergraf 0.5mg is also used to treat in various advanced stage cancer in stomach, intestines or pancreas. CLINICAL PHARMACOLOGY OF EVERGRAF Everolimus is a prohibition of mTOR, links at peak compatibility to FK506 binding protein 12, through producing drug complex which prevents the productive of mTOR. This inhibition reduces the activity of effectors downstream, which may lead to stoppage of cell progression from G1 into S phase, finally causes cell growth arrest and apoptosis. Evergraf also prohibits ...

DESCRIPTION Evergraf 0.25mg belongs to the class of anti-cancer drugs Evergraf 0.25mg contains an active compound known as Everolimus which interferes with the development of cancer cell and the process is slowed down. Evergraf 0.25mg tablets is not a curable medication, which helps to slow their spreading into the body. PRESCRIBED FOR The drug Evergraf 0.25mg is mainly used for the treatment of the following disease • kidney carcinoma • Breast carcinoma • Brain carcinoma Evergraf 0.25mg is also used to treat in various advanced stage cancer in stomach, intestines or pancreas. CLINICAL PHARMACOLOGY OF EVERGRAF Everolimus is a prohibition of mTOR, links at peak compatibility to FK506 binding protein 12, through producing drug complex which prevents the productive of mTOR. This inhibition reduces the activity of effectors downstream, which may lead to stoppage of cell progression from G1 into S phase, finally causes cell growth arrest and apoptosis. Evergraf also pr...